Exogenous hydrogen sulfide (H2S) protects against regional myocardial ischemia–reperfusion injuryEvidence for a role of KATP channels

被引:0
|
作者
D. Johansen
K. Ytrehus
G. F. Baxter
机构
[1] The Royal Veterinary College,Department of Basic Sciences
[2] University of London,Department of Medical Physiology
[3] University of Tromsø,undefined
来源
Basic Research in Cardiology | 2006年 / 101卷
关键词
hydrogen sulfide; ischemia–reperfusion; infarct size; K; channel;
D O I
暂无
中图分类号
学科分类号
摘要
Hydrogen sulfide (H2S) is a gaseous mediator, produced by the metabolic pathways that regulate tissue concentrations of sulfur–containing amino acids. Recent studies indicate that endogenous or exogenous H2S exerts physiological effects in the cardiovascular system of vertebrates, possibly through modulation of KATP channel opening. The present study was undertaken to examine the hypothesis that H2S is cytoprotective against myocardial ischemia–reperfusion injury and that this protective action is mediated by KATP opening. Rat isolated hearts were Langendorff–perfused and underwent 30 min left main coronary artery occlusion and 120 min reperfusion. The resulting injury was assessed as infarct size, determined by tetrazolium staining. Treatment of hearts with the H2S–donor, NaHS, commencing 10 min prior to the onset of coronary occlusion and maintained until 10 min reperfusion, resulted in a concentration–dependent limitation of infarct size (control, 41.0 ± 2.6% of risk zone; NaHS 0.1 μM, 33.9 ± 2.1%, [0.05 > P < 0.1]; NaHS 1 μM, 20.2 ± 2.1% [P < 0.01]). Pretreatment with the KATP channel blockers glibenclamide 10 μM or sodium 5–hydroxydecanoate (5HD) 100 μM led to abrogation of the infarct–limiting effect of NaHS 1 μM (glibenclamide + NaHS 42.5 ± 3.6%; 5HD + NaHS 44.7 ± 2.2%). No statistically significant effects of NaHS treatment on coronary flow, heart rate or left ventricular developed pressure were observed in this experimental preparation. These data provide the first evidence that exogenous H2S protects against irreversible ischemia–reperfusion injury in myocardium and support the involvement of KATP opening in the mechanism of action. Further work is required to elucidate the potential role of endogenous H2S as a cytoprotective mediator against myocardial ischemia–reperfusion injury, the mechanisms regulating its generation, and the nature of its interaction with protein targets such as the KATP channel.
引用
收藏
页码:53 / 60
页数:7
相关论文
共 50 条
  • [41] Exogenous Hydrogen Sulfide (H2S) Reduces Blood Pressure and Prevents the Progression of Diabetic Nephropathy in Spontaneously Hypertensive Rats
    Ahmad, Fiaz Ud Din
    Sattar, Munavvar Abdul
    Rathore, Hassaan Anwer
    Abdullah, Mohammed Hadi
    Tan, Samual
    Abdullah, Nor Azizan
    Johns, Edward James
    RENAL FAILURE, 2012, 34 (02) : 203 - 210
  • [42] Exogenous Hydrogen Sulfide Offers Neuroprotection on Intracerebral Hemorrhage Injury Through Modulating Endogenous H2S Metabolism in Mice
    Shan, Haiyan
    Qiu, Jianping
    Chang, Pan
    Chu, Yang
    Gao, Cheng
    Wang, Haocheng
    Chen, Guang
    Luo, Chengliang
    Wang, Tao
    Chen, Xiping
    Zhang, Mingyang
    Tao, Luyang
    FRONTIERS IN CELLULAR NEUROSCIENCE, 2019, 13
  • [43] A CRITICAL REVIEW ON PHARMACOLOGICAL SIGNIFICANCE OF HYDROGEN SULFIDE (H2S) ON NF-κB CONCENTRATION AND ICAM-1 EXPRESSION IN RENAL ISCHEMIA REPERFUSION INJURY
    Hashmi, Syed Fayaz
    Sattar, Munavvar Z. A.
    Rathore, Hassaan A.
    Ahmad, Ashfaq
    Johns, Edward J.
    ACTA POLONIAE PHARMACEUTICA, 2017, 74 (03): : 747 - 752
  • [44] Exogenous and Endogenous Hydrogen Sulfide Protects Gastric Mucosa against the Formation and Time-Dependent Development of Ischemia/Reperfusion-Induced Acute Lesions Progressing into Deeper Ulcerations
    Magierowski, Marcin
    Magierowska, Katarzyna
    Hubalewska-Mazgaj, Magdalena
    Sliwowski, Zbigniew
    Pajdo, Robert
    Ginter, Grzegorz
    Kwiecien, Slawomir
    Brzozowski, Tomasz
    MOLECULES, 2017, 22 (02)
  • [45] Role of Human Sulfide: Quinone Oxidoreductase in H2S Metabolism
    Jackson, Michael R.
    Melideo, Scott L.
    Jorns, Marilyn Schuman
    HYDROGEN SULFIDE IN REDOX BIOLOGY, PT A, 2015, 554 : 255 - 270
  • [46] Hydrogen sulfide provides cardioprotection against myocardial/ischemia reperfusion injury in the diabetic state through the activation of the RISK pathway
    Lambert, Jonathan P.
    Nicholson, Chad K.
    Amin, Hena
    Amin, Sana
    Calvert, John W.
    MEDICAL GAS RESEARCH, 2014, 4
  • [47] H2S Protecting against Lung Injury following Limb Ischemia-reperfusion by Alleviating Inflammation and Water Transport Abnormality in Rats
    Qi Ying Chun
    Chen Wen
    Li Xiao Ling
    Wang Yu Wei
    Xie Xiao Hua
    BIOMEDICAL AND ENVIRONMENTAL SCIENCES, 2014, 27 (06) : 410 - 418
  • [48] Hydrogen sulfide (H2S) signaling in plant development and stress responses
    Liu, Hai
    Wang, Jicheng
    Liu, Jianhao
    Liu, Tong
    Xue, Shaowu
    ABIOTECH, 2021, 2 (01) : 32 - 63
  • [49] Vasodilator activity of hydrogen sulfide (H2S) in human mesenteric arteries
    Materazzi, Serena
    Zagli, Giovanni
    Nassini, Romina
    Bartolini, Ilenia
    Romagnoli, Stefano
    Chelazzi, Cosimo
    Benemei, Silvia
    Coratti, Andrea
    De Gaudio, Angelo Raffaele
    Patacchini, Riccardo
    MICROVASCULAR RESEARCH, 2017, 109 : 38 - 44
  • [50] The protective role of the 3-mercaptopyruvate sulfurtransferase (3-MST)-hydrogen sulfide (H2S) pathway against experimental osteoarthritis
    Nasi, Sonia
    Ehirchiou, Driss
    Chatzianastasiou, Athanasia
    Nagahara, Noriyuki
    Papapetropoulos, Andreas
    Bertrand, Jessica
    Cirino, Giuseppe
    So, Alexander
    Busso, Nathalie
    ARTHRITIS RESEARCH & THERAPY, 2020, 22 (01)